When.com Web Search

  1. Ads

    related to: next gen sequencing companies prices

Search results

  1. Results From The WOW.Com Content Network
  2. Massive parallel sequencing - Wikipedia

    en.wikipedia.org/wiki/Massive_parallel_sequencing

    This design is very different from that of Sanger sequencing—also known as capillary sequencing or first-generation sequencing—which is based on electrophoretic separation of chain-termination products produced in individual sequencing reactions. [6] This methodology allows sequencing to be completed on a larger scale. [7]

  3. New England Biolabs - Wikipedia

    en.wikipedia.org/wiki/New_England_Biolabs

    New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. [2] It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. [3]

  4. Clear Labs - Wikipedia

    en.wikipedia.org/wiki/Clear_Labs

    Clear Labs Raised a $60M Series C round led by Morgan Stanley and T. Rowe Price in May 2021. [19] Clear Labs has also received governmental and professional certification for its food safety next generation sequencing platform, including from the International AOAC [20] in December 2019 and the National Poultry Improvement Plan in October 2021 ...

  5. DNAnexus - Wikipedia

    en.wikipedia.org/wiki/DNAnexus

    The SRA was started by NCBI in 2007 to collect sequence data produced by next-generation sequencing instruments. [17] DNAnexus developed a new web interface for the SRA and worked with Google to host more than 350 terabytes of DNA sequence data. [ 18 ]

  6. Sophia Genetics - Wikipedia

    en.wikipedia.org/wiki/Sophia_Genetics

    In 2016, Sophia Genetics entered into a comarketing agreement with Illumina allowing the two companies to promote adoption of next- generation DNA sequencing. [18]In 2019, Sophia Genetics formed partnerships with Integrated DNA Technologies and Paragon Genomics, next-generation sequencing (NGS) assay development company, to provide COVID-19 test kits [19] [20]

  7. Natera - Wikipedia

    en.wikipedia.org/wiki/Natera

    In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA." [3] In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only.

  1. Ads

    related to: next gen sequencing companies prices